Get started Log in

BSPM — Biostar Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Market Cap
$0.00m
Enterprise Value
$2.06m
Revenue
$2.38m

Brief: Biostar Pharmaceuticals Announces Receipt Of Additional Delisting Determination Letter From Nasdaq
23/08/2018 13:58
U.S. STOCKS ON THE MOVE-Twitter, Intel, Amazon, Exxon Mobil, Starbucks
27/07/2018 16:02
NASDAQ RESUMED
26/07/2018 15:13
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
26/07/2018 15:08
NASDAQ RESUMED
26/07/2018 15:06
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
26/07/2018 15:01
NASDAQ RESUMED
26/07/2018 15:00
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE
26/07/2018 14:55
Brief: Biostar Pharmaceuticals Says Says Ronghua Wang Agreed To Sell His 426,999 Shares Of Co In Private Sale To Waiping Liu At $1.57/Share
06/07/2018 21:42
Brief: Waiping Liu Says Plans To Nominate New Chairman At Biostar Pharmaceuticals
02/07/2018 22:13
Brief: Biostar Pharmaceuticals Files For Non-Timely 10-Q
16/05/2018 21:14
Brief: Biostar Announces Receipt Of Nasdaq Continued Listing Deficiency Notice
23/04/2018 21:32
Brief: Biostar Pharmaceuticals Files For Non-Timely 10-K With U.S. SEC
02/04/2018 21:11
Brief: Biostar Pharmaceuticals Announces Plans To Launch A New Ecommerce Sales Platform
21/02/2018 14:00
Brief: Biostar Says Shaanxi Aoxing Renewed GMP Certification
07/02/2018 14:03
Brief: Biostar Regains Compliance With Nasdaq Continued Listing Requirement
04/12/2017 21:35
Brief: Biostar Pharma qtrly loss per share $0.05
20/11/2017 21:01
Brief: Biostar Pharmaceuticals qtrly loss per share $0.50
15/11/2017 21:30
Brief: Biostar Pharmaceuticals Inc files non-timely 10-Q
15/08/2017 14:04
Brief: Biostar Pharmaceuticals Inc anticipates production of Shaanxi Weinan products will resume in first half of 2017
13/04/2017 21:00